Evidence map›Paper›PMID 35538097›Full record

ArticleNature communications2022

Systematic and quantitative view of the antiviral arsenal of prokaryotes.

Florian Tesson, Alexandre Hervé, Ernest Mordret, Marie Touchon, Camille d'Humières, Jean Cury, Aude Bernheim

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 496 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
496citing papers in PubMed, 1 pooled it
110.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

496 citing papers in PubMed, 1 synthesis or guideline pooled it, 709 citations in OpenAlex.

  1. Pooled it
  2. Engineering the probioticSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. How bacterial immune systems sense phage infection.Nature reviews. Microbiology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Oxytetracycline ProducerInternational journal of molecular sciences · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

436 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Florian TessonUniversité de Paris, IAME, UMR 1137, INSERM, Paris, France.
Alexandre HervéIndependent Researcher, Paris, France.
Ernest MordretSEED, U1284, INSERM, Université de Paris, Paris, France.
Marie TouchonInstitut Pasteur, Université de Paris, CNRS, UMR3525, Microbial Evolutionary Genomics, Paris, 75015, France.ORCID 0000-0001-7389-447X
Camille d'HumièresUniversité de Paris, IAME, UMR 1137, INSERM, Paris, France.
Jean CurySEED, U1284, INSERM, Université de Paris, Paris, France. jean.cury@normalesup.org.ORCID 0000-0002-6462-8783
Aude BernheimUniversité de Paris, IAME, UMR 1137, INSERM, Paris, France. aude.bernheim@inserm.fr.ORCID 0000-0003-0212-777X
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria and archaea have developed multiple antiviral mechanisms, and genomic evidence indicates that several of these antiviral systems co-occur in the same strain. Here, we introduce DefenseFinder, a tool that automatically detects known antiviral systems in prokaryotic genomes. We use DefenseFinder to analyse 21000 fully sequenced prokaryotic genomes, and find that antiviral strategies vary drastically between phyla, species and strains. Variations in composition of antiviral systems correlate with genome size, viral threat, and lifestyle traits. DefenseFinder will facilitate large-scale genomic analysis of antiviral defense systems and the study of host-virus interactions in prokaryotes.

Indexed as

Antiviral AgentsArchaeaBacteriaGenomicsProkaryotic CellsAntiviral Agents

Identifiers

PMID35538097
PMCPMC9090908
OpenAlexW4229443239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.